MedPath

Virtual Reality to Reduce Periprocedural Anxiety During Invasive Coronary Angiography

Not Applicable
Recruiting
Conditions
Anxiety State
Anxiety
Registration Number
NCT06215456
Lead Sponsor
Radboud University Medical Center
Brief Summary

Introduction Patients undergoing invasive coronary angiography experience anxiety due to various factors. This can lead to physiological and psychological complications, compromising patient comfort and overall procedural outcomes. Benzodiazepines are commonly used to reduce periprocedural anxiety, although the effect is modest. VR is an promising nonpharmacological intervention that can be used to reduce anxiety in patients undergoing an invasive coronary angiography.

Methods and analysis A single-center open-label randomized controlled trial was performed to assess the effectiveness of add-on VR therapy on anxiety in 100 patients undergoing invasive coronary angiography and experiencing anxiety in periprocedural setting. The primary outcome is the NRS anxiety score measured just before obtaining arterial access. Secondary outcomes are physiological measures of anxiety and the State-Trait Anxiety Inventory, Perceived Stress Scale, and IGroup presence questionnaire. The NRS anxiety level and physiological measurements will be taken at five scheduled times between pre procedural, peri and post procedural. The State-Trait Anxiety Inventory and Perceived Stress Scale will be performed prior to coronary angiography and the State-Trait Anxiety Inventory (state form) and the IGroup Presence questionnaire will be performed post-intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patient ≥16 years undergoing elective cardiac catheterisation
  • Patient is willing and able to comply with the study protocol
  • NRS anxiety score ≥ 4
Exclusion Criteria
  • History of dementia
  • Severe hearing/visual impairment not corrected
  • Depression or anxiety disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
NRS anxietyAssessed at established moment right before start op procedure.

Numeric rating score for anxiety with 0 representing no anxiety and 10 the worst anxiety imaginable.

Secondary Outcome Measures
NameTimeMethod
Total finished VR sessionst5 10min after end of procedure

Only taken in intervention group.

anxiolytics useAt t2 20 minutes after t1 right before patients transfers to procedure room and t5 10min after end of procedure

Use of benzodiazepines (yes/no) was registered for each patient

NRS anxietyAt set moments: t0 baseline, t1 20-25min preprocedural, t2 20min after t1 right before transfer to procedure room, t3 5 minutes before start procedure, t4 during procedure (directly after arterial access), t5 10min after end of procedure

Numeric rating score for anxiety with 0 representing no anxiety and 10 the worst anxiety

blood pressureAt set moments: t0 baseline, t1 20-25min preprocedural, t2 20min after t1 right before transfer to procedure room, t3 5 minutes before start procedure, t4 during procedure (directly after arterial access), t5 10min after end of procedure

Both systolic and diastolic blood pressure will be measured

heart rate variabilityAt set moments: t0 baseline, t1 20-25min preprocedural, t2 20min after t1 right before transfer to procedure room, t3 5 minutes before start procedure, t4 during procedure (directly after arterial access), t5 10min after end of procedure

SDNN (standard deviation of the NN (R-R) intervals) is extracted

respiration rateAt set moments: t0 baseline, t1 20-25min preprocedural, t2 20min after t1 right before transfer to procedure room, t3 5 minutes before start procedure, t4 during procedure (directly after arterial access), t5 10min after end of procedure
Igroup presence questionnairet5 10min after end of procedure

Assesses the presence in the virtual environment, only taken in intervention group.

heart rateAt set moments: t0 baseline, t1 20-25min preprocedural, t2 20min after t1 right before transfer to procedure room, t3 5 minutes before start procedure, t4 during procedure (directly after arterial access), t5 10min after end of procedure
STAI-traitAt t0 baseline

State-Trait Anxiety Inventory - trait section - 20 item. Score range 20-80. Higher score is higher anxiety.

Patient satisfactionAt t5 10min after end of procedure

Measured using NRS score, with 0 completely dissatisfied and 10 completely satisfied

complexity of procedureAt t5 10min after end of procedure

Reported by cardiologist in categories: less complex than anticipated - as anticipated - more complex than anticipated.

STAI-state short formAt t0 baseline and t5 10min after end of procedure

State-Trait Anxiety Inventory - state section - 6 item. Score range 6-24. Higher score is higher anxiety.

Perceived stress questionnaireAt t0 baseline

The PSS gives an indication about the feelings and thoughts during the past month of the patient. Score range 0-40. Higher score means higher perceived stress.

Pain during arterial punctionAt t4 during procedure (directly after arterial access)

Measured using NRS score, with 0 representing no pain and 10 worst pain imaginable

Cardiologist satisfaction with procedureAt t5 10min after end of procedure

Measured using NRS score, with 0 completely dissatisfied and 10 completely satisfied

Radial artery spasm yes/noAt t5 10min after end of procedure

As reported by cardiologist

Total duration of VR uset5 10min after end of procedure

Only taken in intervention group.

Trial Locations

Locations (1)

Radboud university medical center

🇳🇱

Nijmegen, Gelderland, Netherlands

Radboud university medical center
🇳🇱Nijmegen, Gelderland, Netherlands
Groenveld, MD
Contact
tjitske.groenveld@radboudumc.nl

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.